| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/09/2005 | CA2547430A1 Receptor function regulating agent |
| 06/09/2005 | CA2547126A1 Substance binding human igg fc receptor iib (fcyriib) |
| 06/09/2005 | CA2547034A1 Anticarcinoma antibodies and uses thereof |
| 06/09/2005 | CA2546922A1 Method for adjusting the quantification range of individual analytes in a multiplexed assay |
| 06/09/2005 | CA2546868A1 Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems |
| 06/09/2005 | CA2546771A1 Plks as modifiers of the beta catenin pathway and methods of use |
| 06/09/2005 | CA2546747A1 Ttbks as modifiers of the beta catenin pathway and methods of use |
| 06/09/2005 | CA2546654A1 Polynucleotides overexpressed in breast cancer cells, compositions and methods for the therapy and diagnosis of breast cancer |
| 06/09/2005 | CA2546622A1 Use of isogenic drug-resistant cell lines to determine the sequence of chemotherapeutic drug treatment |
| 06/09/2005 | CA2546619A1 Il-23 and its receptor; related reagents and methods |
| 06/09/2005 | CA2546589A1 Hydrometric measurement transmitter and assembly |
| 06/09/2005 | CA2546562A1 System and method for identifying structures for a chemical compound |
| 06/09/2005 | CA2546498A1 Peptide increasing fusiogenic capacity of a gamete |
| 06/09/2005 | CA2546461A1 Methods for diagnosis, stratification, and monitoring of alzheimer`s disease |
| 06/09/2005 | CA2546420A1 Apparatus and methods for assessing metabolic substrate utilization |
| 06/09/2005 | CA2546416A1 Use of parasitic biological agents for diseases prevention and control |
| 06/09/2005 | CA2546343A1 Methods for purifying pertussis toxin and peptides useful therefor |
| 06/09/2005 | CA2546184A1 Fluid monitoring apparatus and method |
| 06/09/2005 | CA2545653A1 Asymmetrically branched polymer conjugates and microarray assays |
| 06/09/2005 | CA2545553A1 Methods for producing olfactory gpcrs |
| 06/09/2005 | CA2544939A1 Gas sensor device |
| 06/08/2005 | EP1538445A2 Immunochromatography system and method for the simultaneous identification of aga and t-tg antibodies and use thereof for the diagnosis of celiac disease |
| 06/08/2005 | EP1538444A1 Testing device |
| 06/08/2005 | EP1538443A1 Rapid diagnosis apparatus comprising locking means actuated by test strips |
| 06/08/2005 | EP1538438A1 Gasoline type identifying system and method for identifying gasoline type |
| 06/08/2005 | EP1538436A1 Method for measuring surface plasmon resonance |
| 06/08/2005 | EP1538217A1 Method of screening insulin content enhancer |
| 06/08/2005 | EP1538209A2 Self-assembling recombinant hpv16 papillomavirus capsid proteins |
| 06/08/2005 | EP1538162A2 Compositions for altering mucus secretion |
| 06/08/2005 | EP1538157A2 Isolation and use of SH3 binding peptides |
| 06/08/2005 | EP1538156A1 Versatile linker compound and ligand, and method for preparation thereof |
| 06/08/2005 | EP1537915A2 Reaction vessel |
| 06/08/2005 | EP1537878A1 Immunopotentiating compositions |
| 06/08/2005 | EP1537822A1 Blood sugar level measuring apparatus |
| 06/08/2005 | EP1537778A2 Body fat measuring device |
| 06/08/2005 | EP1537533A2 Tissue image analysis for cell classification and laser capture microdissection applications |
| 06/08/2005 | EP1537423A1 Method for the local detection of inflammation and allergy mediators |
| 06/08/2005 | EP1537422A2 Isoprostanes as markers of psychological stress in humans |
| 06/08/2005 | EP1537421A2 A method for the identification of drug targets |
| 06/08/2005 | EP1537420A2 Method of diagnosis of pregnancy-related complications |
| 06/08/2005 | EP1537419A2 Cytokine production-inducing antibody |
| 06/08/2005 | EP1537418A2 Method for isolating hepatitis c virus peptides |
| 06/08/2005 | EP1537417A2 Method of diagnosing colon and gastric cancers |
| 06/08/2005 | EP1537416A1 Device for analysing analyte compounds and use hereof |
| 06/08/2005 | EP1537415A2 Methods of diagnosing cervical cancer |
| 06/08/2005 | EP1537414A1 Device for measuring the quality of slaughtered animals or food items |
| 06/08/2005 | EP1537413A1 Gas supply adapter |
| 06/08/2005 | EP1537411A2 System and methods for electrophoretic separation of proteins on protein binding membranes |
| 06/08/2005 | EP1537410A1 Hydrogen sensing apparatus and method |
| 06/08/2005 | EP1537403A2 High throughput microbalance and methods of using same |
| 06/08/2005 | EP1537400A1 Method and device for taking indoor air samples |
| 06/08/2005 | EP1537384A2 Method for monitoring sensor function |
| 06/08/2005 | EP1537263A2 Semiconductor nanocrystal heterostructures |
| 06/08/2005 | EP1537244A1 Method for detecting biomolecules |
| 06/08/2005 | EP1537243A1 Method of diagnosing ovarian endometriosis |
| 06/08/2005 | EP1537242A1 Method for preparation of cdna tags for identifying expressed genes and method for analysis of gene expression |
| 06/08/2005 | EP1537241A1 Use of an analysing substance for detecting an explosive |
| 06/08/2005 | EP1537237A2 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 06/08/2005 | EP1537235A2 Diagnostic assays for parvovirus b19 |
| 06/08/2005 | EP1537231A1 Amp-activated protein kinase (ampk) inhibitor screening assay |
| 06/08/2005 | EP1537230A1 Fluorescent enzyme assay methods and compositions |
| 06/08/2005 | EP1537212A2 Human lipid phosphate phosphatases and uses thereof for treating neuronal diseases |
| 06/08/2005 | EP1537206A2 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 06/08/2005 | EP1537205A2 Viral deconstruction through capsid assembly in vitro |
| 06/08/2005 | EP1537202A2 Methods and reagents for surface functionalization |
| 06/08/2005 | EP1537187A2 Organic species that facilitate charge transfer to or from nanostructures |
| 06/08/2005 | EP1537148A1 Antibodies isolating and/or identifying neuronal stem cells and method for isolating and/ or identifying neuronal precursor cells |
| 06/08/2005 | EP1537140A2 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
| 06/08/2005 | EP1537139A2 A mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism |
| 06/08/2005 | EP1537138A2 Receptors and membrane-associated proteins |
| 06/08/2005 | EP1537137A2 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 06/08/2005 | EP1536834A2 Design of chemokine analogs for the treatment of human diseases |
| 06/08/2005 | EP1536831A2 Pharmaceutical liposomal compositions containing n. meningitidis derived polypeptides or polynucleotides |
| 06/08/2005 | EP1536828A2 Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 06/08/2005 | EP1536827A1 Use of protein kinase n beta |
| 06/08/2005 | EP1536821A1 Inhibition of t cell activation by butyrophilin 4 or b7-l1 |
| 06/08/2005 | EP1536818A2 Fibrinogen binding moieties |
| 06/08/2005 | EP1536814A2 Antibodies to non-shed muc1 and muc16, and uses thereof |
| 06/08/2005 | EP1536812A2 Methods for modulating activity of the fxr nuclear receptor |
| 06/08/2005 | EP1536778A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 06/08/2005 | EP1536729A2 Monitoring blood glucose including convenient display of measurement values |
| 06/08/2005 | EP1497469A4 Assay for evaluation of activity of compounds against hcv using a novel detection system in the hcv replicon |
| 06/08/2005 | EP1490665A4 Rapid and non-invasive method to evaluate immunization status of a patient |
| 06/08/2005 | EP1487861A4 Treating solution containing aluminium ion for staining protein and staining method using the same |
| 06/08/2005 | EP1448987A4 Systems and methods for obtaining data correlated patient samples |
| 06/08/2005 | EP1420888B1 System for separating magnetically attractable particles |
| 06/08/2005 | EP1399580A4 Secretion of proteins by encapsulated cells |
| 06/08/2005 | EP1368654A4 Multiplex protein interaction determinations using glutathione-gst binding |
| 06/08/2005 | EP1278890A4 A method of detecting neoplastic or non-neoplastic cells |
| 06/08/2005 | EP1263301A4 Method and system for assay and removal of harmful toxins during processing of tobacco products |
| 06/08/2005 | EP1206488B1 Method for isolating and purifying grass pollen allergens |
| 06/08/2005 | EP1165888B1 Paint and paper coated with said paint |
| 06/08/2005 | EP1097174B1 Lupus anticoagulant antibody to f1 region of prothrombin |
| 06/08/2005 | EP1092017A4 Novel gaba-b receptor |
| 06/08/2005 | EP1077770B1 Sample introduction device |
| 06/08/2005 | EP1047937B1 Screening method for apoptosis and necrosis |
| 06/08/2005 | EP1003501B9 Use of an agent for lowering the risk of cardiovascular disease |
| 06/08/2005 | EP0946122B1 Apparatus for obtaining blood for diagnostic tests |
| 06/08/2005 | EP0922387B1 Method of screening elicitor inducing the production of phytoalexin in rice and rice disease controlling agent containing elicitor as the active ingredient |
| 06/08/2005 | EP0756633B1 Method and kits for processing mycobacteria and mycolic acid containing bacteria |